lanperisone has been researched along with carboxyamido-triazole in 1 studies
| Studies (lanperisone) | Trials (lanperisone) | Recent Studies (post-2010) (lanperisone) | Studies (carboxyamido-triazole) | Trials (carboxyamido-triazole) | Recent Studies (post-2010) (carboxyamido-triazole) |
|---|---|---|---|---|---|
| 11 | 0 | 10 | 105 | 15 | 22 |
| Protein | Taxonomy | lanperisone (IC50) | carboxyamido-triazole (IC50) |
|---|---|---|---|
| galanin receptor type 3 | Homo sapiens (human) | 1.8696 | |
| COUP transcription factor 2 isoform a | Homo sapiens (human) | 9.206 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frett, B; Kaiser, CE; Li, HY; Wang, Y | 1 |
1 review(s) available for lanperisone and carboxyamido-triazole
| Article | Year |
|---|---|
Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators.
Topics: Cell Cycle Proteins; Humans; Models, Biological; Molecular Structure; Molecular Targeted Therapy; Mutation; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; ras Proteins; Signal Transduction; Small Molecule Libraries | 2013 |